Morphine Sulfate 50mcg for Anesthesia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
AnesthesiaMorphine Sulfate 50mcg - Drug
Eligibility
Any Age
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether a lower dose of morphine given through an epidural decreases side effects, compared to a higher dose.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: One assessment during hospital stay - up to postoperative day 2 (2 days following cesarean delivery)

Day 2
Outcome of side effects of intervention: nausea
Day 2
Outcome of side effects of intervention: pruritus
Outcome of side effects of intervention: urinary retention
One measurement during entire hospital stay
Maternal from intervention
Within first hour of birth
Neonatal from intervention

Trial Safety

Trial Design

2 Treatment Groups

Group A: 150 mcg morphine
1 of 2
Group B: 50 mcg morphine
1 of 2

Active Control

Experimental Treatment

96 Total Participants · 2 Treatment Groups

Primary Treatment: Morphine Sulfate 50mcg · No Placebo Group · Phase < 1

Group B: 50 mcg morphine
Drug
Experimental Group · 1 Intervention: Morphine Sulfate 50mcg · Intervention Types: Drug
Group A: 150 mcg morphine
Drug
ActiveComparator Group · 1 Intervention: Morphine Sulfate 150 mcg · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: one assessment during hospital stay - up to postoperative day 2 (2 days following cesarean delivery)

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,432 Previous Clinical Trials
2,218,974 Total Patients Enrolled
Brian Casey, MDPrincipal InvestigatorUniversity of Alabama at Birmingham
1 Previous Clinical Trials
1,203 Total Patients Enrolled

Eligibility Criteria

Age Any Age · Female Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References